Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation

Clinical trial NCT06041490 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06041490
Sponsor: Peking Union Medical College Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Liver Transplant; Complications Hepatocarcinoma Recurrent Osteosarcoma High-Risk Cancer

Start date: 2023-09-01
Primary completion: 2026-06-01
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.